The Securities and Exchange Board of India (SEBI) recently added two more names to the upcoming IPO pipeline by clearing IPOs of RK Steel Manufacturing and Hindustan Laboratories. Let’s take a look at the latest IPO approval this week.
RK Steel IPO Approval
RK Steel Manufacturing Company specialises in the production of high-grade welded steel tubes and pipes. Based in Tamil Nadu, the company operates an integrated manufacturing facility that produces HR, GP, and CRCA variants essential for the construction, automotive, and infrastructure sectors. The company has a production capacity of 1,50,000 tons per annum
The company submitted its DRHP on 01 October 2025. SEBI issued its final observation letter on 27 April 2026. According to the filing, the RK Steel IPO is a Fresh Issue comprising up to 2,00,00,000 equity shares with a face value of INR 10 each.
Hindustan Laboratories IPO Approval
Hindustan Laboratories is a B2G generic medicine supplier. Established in 2017, the company focuses on manufacturing and supplying essential generic formulations, including anti-diabetics and cardiac care medicines, to various state and central government healthcare agencies. With a WHO-GMP-certified facility in Palghar, Maharashtra, the company supplies across 27 Indian states.
The pharmaceutical firm filed its DRHP with the regulator on 6 January 2026 and received the IPO approval this week on 27 April 2026. The Hindustan Laboratories IPO is structured as a mix Fresh + OFS, totalling 1,41,00,000 equity shares. Choice Capital Advisors is the lead manager of the IPO.
Latest Content From IPO Central
Rajat Bhati has a strong technical background and 5 years of experience in the stock market. He focuses on equity research, technical analysis, IPO valuations, and risk management, helping investors make clearer, data-backed decisions. Today, he works full-time to educate people about the opportunities in IPO market.
